Guangzhou Baiyunshan Pharmaceutical Co. of  Guangzhou Pharma plans to invest RMB 700mln in building 2 new manufacturing bases to produce the renowed Wanglaoji herbal tea. 

The two new bases locate in Guangdong Province and Hunan Province, respectively. After completion, the 2 new bases will be able to extract, produce and bottle 40 tonnes herbal tea syrup and 20mln standard cases of Wanglaoji Herbal Tea.